- Home
- JFU vs VVOS Comparison
JFU vs VVOS Comparison
Compare JFU & VVOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JFU
- VVOS
- Stock Information
- Founded
- JFU 2006
- VVOS 2016
- Country
- JFU China
- VVOS United States
- Employees
- JFU N/A
- VVOS N/A
- Industry
- JFU Finance: Consumer Services
- VVOS Medical Specialities
- Sector
- JFU Finance
- VVOS Health Care
- Exchange
- JFU Nasdaq
- VVOS Nasdaq
- Market Cap
- JFU 15.8M
- VVOS 14.8M
- IPO Year
- JFU 2019
- VVOS 2020
- Fundamental
- Price
- JFU $1.40
- VVOS $2.42
- Analyst Decision
- JFU
- VVOS Strong Buy
- Analyst Count
- JFU 0
- VVOS 2
- Target Price
- JFU N/A
- VVOS $6.10
- AVG Volume (30 Days)
- JFU 11.3K
- VVOS 123.7K
- Earning Date
- JFU 01-01-0001
- VVOS 05-15-2025
- Dividend Yield
- JFU N/A
- VVOS N/A
- EPS Growth
- JFU N/A
- VVOS N/A
- EPS
- JFU 0.09
- VVOS N/A
- Revenue
- JFU $40,614,155.00
- VVOS $14,628,000.00
- Revenue This Year
- JFU N/A
- VVOS $17.40
- Revenue Next Year
- JFU N/A
- VVOS $20.89
- P/E Ratio
- JFU $14.97
- VVOS N/A
- Revenue Growth
- JFU N/A
- VVOS 9.47
- 52 Week Low
- JFU $1.01
- VVOS $1.91
- 52 Week High
- JFU $3.60
- VVOS $6.28
- Technical
- Relative Strength Index (RSI)
- JFU 53.69
- VVOS 45.96
- Support Level
- JFU $1.30
- VVOS $2.24
- Resistance Level
- JFU $1.48
- VVOS $2.49
- Average True Range (ATR)
- JFU 0.07
- VVOS 0.25
- MACD
- JFU -0.00
- VVOS -0.02
- Stochastic Oscillator
- JFU 50.00
- VVOS 32.62
About JFU 9F Inc.
9F Inc is a financial account platform integrating and personalizing financial services in China. It provides a range of financial products and services across online lending, wealth management, and payment facilitation, all integrated under a single digital financial account. The company generates the majority of its revenue from Loan facilitation services. All its revenues are generated from the People's Republic of China.
About VVOS Vivos Therapeutics Inc.
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.